Energizing Biopharma’s Oncology Breakthroughs
Perthera partners with biopharma teams to drive precision oncology innovation—bringing more effective treatments to patients, faster. Our real-world datasets and AI-driven insights support the full spectrum of drug development.
Connect with our Biopharma Team to learn more
Perthera delivers a comprehensive suite of data-driven solutions to accelerate your drug development pipeline
Real-World Oncology Data—Built for Precision
Matched clinical, molecular, and outcomes data from thousands of cancer patients, with longitudinal records including frontline and later-line treatment histories. Deep expertise in GI and pancreatic cancers.
Data That Drives Intelligent Trial Design
Stratify patients by molecular subtype, treatment history, or metastatic profile. Identify predictive biomarkers and therapeutic vulnerabilities.
Data for Synthetic Control Arm Creation
Use our real-world data to reduce costs due to patient recruitment and retention, by identifying synthetic control arm vs. more trial participants.
Regulatory and Reimbursement Support
Leverage our real-world evidence for regulatory submissions and payer negotiations. Our data and insights can help support regulatory strategies and market access initiatives to accelerate approval timelines and strengthen reimbursement positions
Transform Your Biopharma Research with Real-World Evidence
Through our partnerships with advocacy organizations like the Pancreatic Cancer Action Network (PanCAN) and the Colorectal Cancer Alliance, Perthera has built a scalable platform that accelerates clinical research, lowers barriers to trial enrollment, and optimizes patient-trial matchmaking.
As a lab-agnostic platform, our data is enriched by molecular output from leading CLIA labs across the diagnostic testing space, including Foundation Medicine, Tempus, Caris, and others.
This compares to a historical average of just 5% for pancreatic cancer patients
From Insight to Impact
Transform your oncology research with Perthera’s high-value clinical datasets. Our recent peer-reviewed study in The Oncologist revealed critical correlations between metastatic site biology and survival outcomes in pancreatic cancer—the kind of actionable insights that can accelerate your drug development pipeline and strengthen regulatory submissions.
Partner with Perthera to unlock breakthrough discoveries that drive clinical success
How We Work with Biopharma
01
Real-World Evidence (RWE) Studies
Generate powerful insights from our rich datasets to support your development strategy, market access, and regulatory filings. Our advanced analytics platform enables sophisticated analyses of treatment patterns, outcomes, and unmet needs.
02
Synthetic Control Arms & Comparator Cohorts
Leverage our real-world data to develop synthetic or external control arms for single-arm trials, potentially reducing the need for randomization. Optimize your trial design with carefully matched historical controls.
03
Biomarker Discovery & Validation
Identify and validate predictive biomarkers across diverse, real-world populations—not just clinical trial cohorts. Our molecular and clinical data integration enables robust biomarker analysis to guide patient selection strategies.
04
Custom Patient Cohort Development
Create tailored patient cohorts based on specific molecular profiles, treatment history, or clinical characteristics to support your research objectives. Our precision matching capabilities help identify ideal candidates for your trials.
05
Regulatory and Reimbursement Support
Strengthen your regulatory submissions and payer negotiations with robust real-world evidence. Our data and insights can help address regulatory questions, support label expansions, and demonstrate real-world effectiveness and safety to maximize product value and optimize market access.
Let’s Build Smarter Trials, Together
We are passionate about extending the lives of people with cancer. With our data and expertise, we can help you de-risk clinical programs, improve trial efficiency, and support regulatory and market access strategies.
Contact Our Biopharma Team